HomeCRVS • NASDAQ
add
Corvus Pharmaceuticals Inc
Previous close
$3.03
Day range
$3.02 - $3.37
Year range
$1.30 - $10.00
Market cap
220.76M USD
Avg Volume
733.90K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.10M | 43.99% |
Net income | -12.11M | -82.07% |
Net profit margin | — | — |
Earnings per share | -0.14 | -2.07% |
EBITDA | -8.08M | -44.35% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 51.96M | 91.40% |
Total assets | 68.91M | 51.27% |
Total liabilities | 36.34M | 429.03% |
Total equity | 32.57M | — |
Shares outstanding | 68.14M | — |
Price to book | 6.31 | — |
Return on assets | -31.73% | — |
Return on capital | -87.24% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -12.11M | -82.07% |
Cash from operations | -8.46M | -63.83% |
Cash from investing | -6.08M | -162.42% |
Cash from financing | 18.61M | — |
Net change in cash | 4.06M | 154.24% |
Free cash flow | -16.24M | -397.09% |
About
Founded
2014
Headquarters
Website
Employees
31
